<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39357144</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-426X</ISSN><JournalIssue CitedMedium="Internet"><Volume>545</Volume><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Carbohydrate research</Title><ISOAbbreviation>Carbohydr Res</ISOAbbreviation></Journal><ArticleTitle>Synthesis and pharmacological evaluation of nature-inspired phenacyl glycosides.</ArticleTitle><Pagination><StartPage>109281</StartPage><MedlinePgn>109281</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.carres.2024.109281</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0008-6215(24)00260-X</ELocationID><Abstract><AbstractText>Phenylethanoid glycosides are a well-studied class of bioactive compounds found throughout the plant kingdom. In contrast, research on the synthesis and pharmacological activity of phenacyl glycosides, a specific subgroup of phenylethanoid glycosides with a ketone functionality at the alpha position of the phenol ring, has been limited. In this study, we report the synthesis, cytotoxic, antiviral, and anti-inflammatory evaluation of a series of 18 4'-hydroxyphenacyl glycosides. These compounds consist of six different sugar residues (β-d-glucose, β-d-galactose, α-l-arabinose, β-d-xylose, α-l-rhamnose, and β-d-glucuronic acid) and display three distinct methoxylation patterns at the phenacyl ring, similar to the substitution motifs of anthocyanins. We obtained the target phenacyl glycosides in high yield and stereoselectivity through the coupling of benzoyl-protected trichloroacetimidate glycosyl donors and corresponding acetophenones. Our work represents the first total synthesis of the natural products 4'-hydroxyphenacyl-β-d-glucopyranoside (1) and 4'-hydroxy-3'-methoxyphenacyl-β-d-glucopyranoside (2). None of the phenacyl glycosides showed cytotoxicity against the tested cell lines. Notably, several of the synthesized compounds exhibited antiviral activity, with natural product 2 being the most active against herpes simplex virus type 1, while phenacyl arabinoside 9 and natural product 2 were the most active against human coronavirus OC43. Natural product 2 significantly inhibited the production of interleukin-6 in lipopolysaccharide-stimulated microglia cells. Overall, our findings highlight the importance of the sugar residue and phenacyl ring substitution pattern in modulating the antiviral activity of phenacyl glycosides. Natural product 2 and phenacyl arabinoside 9 emerge as promising leads for the development of antiviral agents.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Delar</LastName><ForeName>Emmanilo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), 531, boulevard des Prairies, Laval, Québec, H7V 1B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tigherghar</LastName><ForeName>Yanis</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), 531, boulevard des Prairies, Laval, Québec, H7V 1B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girard</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Laboratoire LASEVE, Département des Sciences Fondamentales, Université du Québec à Chicoutimi (UQAC), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada; Unité Mixte de Recherche INRS-UQAC, Institut National de la Recherche Scientifique (INRS), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haddad</LastName><ForeName>Mohamed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), 531, boulevard des Prairies, Laval, Québec, H7V 1B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramassamy</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), 531, boulevard des Prairies, Laval, Québec, H7V 1B7, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legault</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratoire LASEVE, Département des Sciences Fondamentales, Université du Québec à Chicoutimi (UQAC), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada; Unité Mixte de Recherche INRS-UQAC, Institut National de la Recherche Scientifique (INRS), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gauthier</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre Armand-Frappier Santé Biotechnologie, Institut National de la Recherche Scientifique (INRS), 531, boulevard des Prairies, Laval, Québec, H7V 1B7, Canada; Laboratoire LASEVE, Département des Sciences Fondamentales, Université du Québec à Chicoutimi (UQAC), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada; Unité Mixte de Recherche INRS-UQAC, Institut National de la Recherche Scientifique (INRS), 555, boulevard de l'Université, Chicoutimi, Québec, G7H 2B1, Canada. Electronic address: charles.gauthier@inrs.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Carbohydr Res</MedlineTA><NlmUniqueID>0043535</NlmUniqueID><ISSNLinking>0008-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anthocyanins</Keyword><Keyword MajorTopicYN="N">Antiviral activity</Keyword><Keyword MajorTopicYN="N">Cytotoxicity</Keyword><Keyword MajorTopicYN="N">Glycosylation</Keyword><Keyword MajorTopicYN="N">Phenacyl glycosides</Keyword><Keyword MajorTopicYN="N">Phenolic compounds</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Charles Gauthier reports financial support was provided by Natural Sciences and Engineering Research Council of Canada. Charles Gauthier reports financial support was provided by Quebec Research Fund Nature and Technology. Charles Gauthier reports financial support was provided by Quebec Health Research Fund. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39357144</ArticleId><ArticleId IdType="doi">10.1016/j.carres.2024.109281</ArticleId><ArticleId IdType="pii">S0008-6215(24)00260-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle>